← All organizations
Highest phase reached
Phase 3
First clinical trial
Apr 1, 2010Last known activity
Nov 30, 2021
Timeline
No events for the selected filters.
Drugs by trial phase (26 distinct, 9 trials)
Phase 3 (16 own, 0 via acquisition)
Phase 2 (7 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Recent trials (14)
- NCT05074147Overall official - principal investigatorPhase 3Nov 30, 2021
- NCT05074147Lead sponsorPhase 3Nov 30, 2021
- NCT05046860Overall official - principal investigatorN/ASep 29, 2021
- NCT04748796CollaboratorN/AFeb 1, 2021
- NCT04672525Overall official - principal investigatorPhase 3Jan 31, 2021
- NCT04672525Lead sponsorPhase 3Jan 31, 2021
- NCT04589546CollaboratorPhase 3Oct 31, 2020
- NCT03378427CollaboratorN/AAug 28, 2018
- NCT03378427Lead sponsorN/AAug 28, 2018
- NCT03378427Study chairN/AAug 28, 2018
- NCT02302547CollaboratorPhase 3Dec 1, 2014
- NCT02302547Overall official - principal investigatorPhase 3Dec 1, 2014
- NCT01757236Overall official - principal investigatorPhase 2Oct 1, 2012
- NCT01033760Overall official - principal investigatorPhase 3Apr 1, 2010
Details
- Last known activity
- Nov 30, 2021